Châtillon, France, November 2, 2026 DBV Technologies to Participate in Upcoming November Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT) (the “Company”), a late-stage biopharmaceutical company, today announced the company will participate at the following investor conferences in November: Guggenheim Securities 3rd Annual Healthcare Innovation Conference – November 9, 2026Format: Fireside ChatTime: 8:00 am ETLocation: Boston, MA 2026 LifeSci
Detailed price information for Transmedics Group Inc (TMDX-Q) from The Globe and Mail including charting and trades.
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of August 31, 2026(Article 223-16 of the Gene...
This is the newest page. Registered accounts read further back.